BerandaMYGN • NASDAQ
add
Myriad Genetics Inc
$5,62
Setelah Jam Perdagangan Normal:(0,00%)0,00
$5,62
Tutup: 30 Jan, 16.03.58 GMT-5 · USD · NASDAQ · Pernyataan Penyangkalan
Tutup sebelumnya
$5,54
Rentang hari
$5,41 - $5,66
Rentang tahun
$3,76 - $15,46
Kapitalisasi pasar
523,86Â jt USD
Volume Rata-Rata
921,79Â rb
Rasio P/E
-
Hasil dividen
-
Bursa utama
NASDAQ
Berita pasar
Keuangan
Laporan Laba Rugi
Pendapatan
Penghasilan bersih
| (USD) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 205,70Â jt | -3,56% |
Biaya operasional | 167,10Â jt | -0,30% |
Penghasilan bersih | -27,40Â jt | -23,98% |
Margin laba bersih | -13,32 | -28,57% |
Penghasilan per saham | 0,00 | -100,00% |
EBITDA | -10,70Â jt | -386,36% |
Tarif pajak efektif | -4,58% | — |
Neraca
Total aset
Total liabilitas
| (USD) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 145,40Â jt | 45,55% |
Total aset | 728,10Â jt | -32,66% |
Total liabilitas | 355,30Â jt | 1,63% |
Total ekuitas | 372,80 jt | — |
Saham yang beredar | 93,21 jt | — |
Harga terhadap nilai buku | 1,38 | — |
Tingkat pengembalian aset | -8,29% | — |
Tingkat pengembalian modal | -10,33% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Penghasilan bersih | -27,40Â jt | -23,98% |
Kas dari operasi | 21,10Â jt | 2.914,29% |
Kas dari investasi | -6,20Â jt | -182,67% |
Kas dari pembiayaan | 56,20Â jt | 1.912,90% |
Perubahan kas bersih | 71,10Â jt | 726,74% |
Arus kas bebas | 20,76Â jt | 27,57% |
Tentang
Myriad Genetics, Inc. is an American genetic testing and precision medicine company based in Salt Lake City, Utah, United States. Myriad employs a number of proprietary technologies that permit doctors and patients to understand the genetic basis of human disease and the role that genes play in the onset, progression and treatment of disease. This information is used to guide the development of new products that assess an individual's risk for developing disease later in life, identify a patient's likelihood of responding to a particular drug therapy, assess a patient's risk of disease progression and disease recurrence, and measure disease activity. Wikipedia
Didirikan
1991
Kantor pusat
Situs
Karyawan
2.700